Skip to main content

Brennan Kevin M.'s Form 4 filing

Xilio Therapeutics, Inc. (XLO) · filed Jan 5, 2026

Accession no.
0001193125-26-002518
Filed
Jan 5, 2026
Trade date
Dec 31, 2025-Jan 2, 2026
Filing delay
5 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.17K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brennan Kevin M.CIK 0001971303Officer (SVP, FINANCE AND ACCOUNTING)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 1, 2026Common StockMOption exerciseAcquired+5,000–F1–8,197Direct
Jan 2, 2026Common StockSSaleDisposed−1,826$0.64−$1,168.646,371Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 31, 2025Common StockAGrant or awardAcquired+95,221$0.00$095,221Direct
Jan 1, 2026Common StockMOption exerciseDisposed−5,000$0.00$010,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units ("RSUs") convert to stock on a one-for-one basis.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)